This inventor holds 5 USPTO granted patents and 2 published patent applications and 1 EPO patent. Top assignees: Johnson & Johnson Research Pty Limited, Gene Shears Pty. Limited. Active years: 1998-2011.
Location History:
- Ryde, AU (1998 - 2000)
- Eastwood, AU (2008 - 2011)
Company Filing History:
3 out of 10 
2 out of 30 Years Active: 1998-2011
Title: Lun-Quan Sun: Innovator in Gene Therapy
Introduction
Lun-Quan Sun is a prominent inventor based in Eastwood, Australia. He has made significant contributions to the field of gene therapy, particularly in the area of hematopoietic progenitor cells. With a total of five patents to his name, his work has the potential to impact the treatment and prevention of various diseases, including HIV.
Latest Patents
Lun-Quan Sun's latest patents include a process for the preparation of a composition of genetically modified hematopoietic progenitor cells. This invention describes compositions and methods related to gene therapy, specifically applied to hematopoietic progenitor cells. The methods outlined aim to provide prolonged engraftment of modified hematopoietic cells in human subjects. Another significant patent focuses on methods for genetic modification of hematopoietic progenitor cells, emphasizing ex vivo gene therapy for the treatment or prevention of HIV infection.
Career Highlights
Throughout his career, Lun-Quan Sun has worked with notable companies such as Johnson & Johnson Research Pty Limited and Gene Shears Pty Limited. His experience in these organizations has allowed him to develop and refine his innovative approaches to gene therapy.
Collaborations
Lun-Quan Sun has collaborated with several professionals in his field, including Geoffrey Phillip Symonds and Rafael G Amado. These collaborations have contributed to the advancement of his research and the successful development of his patents.
Conclusion
Lun-Quan Sun is a key figure in the field of gene therapy, with a focus on hematopoietic progenitor cells. His innovative patents and collaborations highlight his commitment to advancing medical science and improving treatment options for patients.